• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 4. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 5. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Aminopyrimidines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Aminopyrimidines and derivatives

Professional Introduction to 2-Chloro-4-(2-methylpropoxy)pyrimidin-5-amine (CAS No. 1698159-51-1)

2-Chloro-4-(2-methylpropoxy)pyrimidin-5-amine, identified by the Chemical Abstracts Service Number (CAS No.) 1698159-51-1, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic amine derivative exhibits a pyrimidine core, which is a privileged scaffold in medicinal chemistry due to its prevalence in biologically active molecules. The structural motif of this compound incorporates a chloro substituent at the 2-position and an isobutoxy group at the 4-position, alongside an amine functional group at the 5-position. Such structural features make it a versatile intermediate for the development of novel therapeutic agents.

The isobutoxy moiety, specifically the (2-methylpropoxy) part, introduces steric bulk and lipophilicity, which can modulate the pharmacokinetic properties of derivatives derived from this compound. This aspect is particularly valuable in drug design, as it allows for fine-tuning of solubility, permeability, and metabolic stability. The presence of the chloro group at the 2-position further enhances its reactivity, making it a suitable precursor for nucleophilic substitution reactions, which are commonly employed in constructing more complex molecular architectures.

In recent years, there has been growing interest in pyrimidine derivatives as pharmacophores due to their broad spectrum of biological activities. These compounds have been explored for their potential in treating various diseases, including cancer, infectious diseases, and inflammatory disorders. The amine functionality in 2-Chloro-4-(2-methylpropoxy)pyrimidin-5-amine provides a site for further derivatization, enabling the creation of bioactive molecules with tailored properties.

One of the most compelling applications of this compound lies in its utility as a building block for kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways and are frequently dysregulated in diseases such as cancer. By designing pyrimidine-based inhibitors that target specific kinases, researchers aim to develop therapies that can modulate these pathways effectively. The structural features of 2-Chloro-4-(2-methylpropoxy)pyrimidin-5-amine make it an excellent candidate for such applications, as it can be modified to interact with the active sites or allosteric pockets of kinases.

Recent advancements in computational chemistry and high-throughput screening have accelerated the discovery of novel kinase inhibitors. These methods allow researchers to rapidly evaluate large libraries of compounds for their binding affinity and selectivity towards target kinases. 2-Chloro-4-(2-methylpropoxy)pyrimidin-5-amine has been utilized in several virtual screening campaigns due to its promising pharmacological profile. Its ability to serve as a scaffold for generating diverse derivatives has led to the identification of several lead compounds with potent kinase inhibitory activity.

The synthesis of 2-Chloro-4-(2-methylpropoxy)pyrimidin-5-amine involves multi-step organic transformations that highlight its synthetic versatility. The chlorination step at the 2-position can be achieved using reagents such as phosphorus oxychloride (POCl?) or thionyl chloride (SOCl?), while the introduction of the isobutoxy group typically requires nucleophilic substitution reactions employing isobutanol under basic conditions. The final step involves converting the hydroxyl or halogenated intermediate into an amine using appropriate reagents like ammonia or ammonium hydroxide.

The amine functionality at the 5-position not only serves as a site for further derivatization but also contributes to the compound's overall reactivity. This feature allows for modifications such as amidation or alkylation, which can enhance binding interactions with biological targets. Additionally, the presence of both electron-withdrawing (chloro) and electron-donating (isobutoxy) groups creates a balance that can influence electronic properties and interactions with enzymes or receptors.

In conclusion, 2-Chloro-4-(2-methylpropoxy)pyrimidin-5-amine (CAS No. 1698159-51-1) is a multifaceted compound with significant potential in pharmaceutical research and drug development. Its structural features make it an ideal candidate for generating novel bioactive molecules, particularly kinase inhibitors. The ongoing research into pyrimidine derivatives underscores their importance in modern medicine, and compounds like this one continue to play a crucial role in advancing therapeutic strategies.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)